BioGrowing Co., Ltd., a comprehensive probiotics solutions provider specialising in the research, development, production, and sales of probiotics, announces its participation in Pharmtech & Ingredients 2024 in Moscow, Russia, where it will showcase its latest products and research achievements. Founded in 2006 and headquartered in Shanghai, China, BioGrowing is a subsidiary of JUNEYAO Health (605388.SH). The company follows the "5S Probiotic Enterprise Gold Standard" philosophy, which emphasises science-first principles, reliable stability, safety guarantees, pure sourcing, and professional service. With over 20 years of expertise in the probiotics industry, BioGrowing has exported to over 70 countries and regions and was recognised as a top immune and digestive probiotic raw material supplier in the Asia-Pacific region, ranking in the TOP 3 for immune probiotics and TOP 5 for digestive probiotics in 2020. These achievements have established BioGrowing’s strong reputation in the industry.

 

At this exhibition, BioGrowing will showcase its independently developed Flora-focus® series of flagship strains, targeting various health functions, including gut health, immune support, oral health, irritable bowel syndrome, vaginal health, mental health, anti-H.pylori, and weight management. The strains include traditional probiotics, postbiotics, and Weizmannia coagulans. BioGrowing’s Weizmannia coagulans BC-G44 received GRAS certification in 2024, offering high stability and long-lasting activity, making it highly popular in the market. Additionally, we will present various starter culture products and innovative applications to meet evolving market demands.

One of the highlights at the exhibition will be BioGrowing's flagship strain, Lactobacillus plantarum Lp-G18. This strain boasts multiple clinical research results and patents and was recognised as one of the top three "Microbiome Modulation Ingredients of the Year" at the Asia Nutrition Ingredient Awards this September. Lp-G18 produces high levels of glutamine synthetase and has been proven to play a positive role in gut health, combating H.pylori, and enhancing immune responses.

The company adheres to the "5S Probiotic Enterprise Gold Standard" service philosophy. With around 20 years of in-depth experience in the probiotic industry, BioGrowing has exported to 70+ countries and regions. The R&D team comprises over 30 members, with 80% holding doctoral and master's degrees. BioGrowing was recognized as the TOP 3 immune probiotic and TOP 5 digestive probiotic raw material suppliers in the ACPC.
 
 

BioGrowing also has extensive experience in the production of starter cultures, having conducted research in this field since 2009. The products have earned widespread recognition from clients. Its deep-frozen starter cultures are distinguished by stable fermentation times, high vitality, and consistent quality, offering clear advantages over traditional fermentation agents in terms of dosage, solubility speed, ease of use, and cost-effectiveness. This year, BioGrowing established a partnership with a global top-500 dairy company. We have customised a high-quality fermentation agent featuring a unique "Premium Starter Cultures Diamond-Level Six Dimensions" for our clients, covering fermentation activity, post-acidification, texture, aroma, sensory quality, and anti-phage properties. This standard has received unanimous recognition from our numerous clients.
 

We look forward to welcoming you at Pharmtech & Ingredients 2024 at our booth #H7 B5047, where we can discuss the latest advancements in probiotics and fermentation agents. Join us to explore opportunities for deeper collaboration and to drive industry innovation together.
 

Company: BioGrowing Co., Ltd.
Email: cs@biogrowing.com
Tel: +86-21-39205777
Website: www.biogrowing.com